UBS Maintains Buy on Ovintiv, Raises Price Target to $74

Benzinga Newsdesk www.benzinga.com Positive 70.0%

Neg 0% Neu 0% Pos 70%

UBS analyst Josh Silverstein maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $71 to $74.

Comments

No comments yet. Be the first!